A randomized phase II study of 4 or 6 cycles of Adriamycin/Taxol® (paclitaxel) as neoadjuvant treatment of breast cancer.

被引：0

作者：

Fumoleau, P

Tubiana-Hulin, M

Romieu, G

Namer, M

Delva, R

Guastalla, JP

Lotz, JP

Kerbrat, P

Pujade-Lauraine, E

Eichler, F

Dohollou, N

MacGrogan, G

Quinaux, E

Grau, B

机构：

[1] Ctr Rene Gauducheau, F-44035 Nantes, France

[2] Ctr Rene Huguenin, St Cloud, France

[3] Ctr Val Aurelle, Montpellier, France

[4] Ctr Antoine Lacassagne, F-06054 Nice, France

[5] Ctr P Papin, Angers, France

[6] Ctr Leon Berard, F-69373 Lyon, France

[7] Hop Tenon, F-75970 Paris, France

[8] Ctr E Marquis, Rennes, France

[9] Hop Hotel Dieu, Paris, France

[10] Hop Civil, Strasbourg, France

[11] Polyclin Nord Aquitaine, Bordeaux, France

[12] Inst Bergonie, Bordeaux, France

[13] IDDI, Brussels, Belgium

[14] Bristol Myers Squibb Co, Paris, France

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

508

引用

页码：298 / 298

页数：1

共 50 条

[1] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
Ron, IG
Sarid, DL
Wigler, N
Inbar, MJ
[J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
[2] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
Sarid, David
Ron, Ilan G.
Sperber, Fani
Stadler, Yona
Kahan, Perry
Kovner, Felix
Ben-Yosef, Rami
Marmor, Sylvia
Grinberg, Yulia
Maimon, Natalie
Weinstein, Juliana
Yaal-Hahoshen, Neora
[J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
[3] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: A phase II study.
Sarid, D
Ron, I
Inbar, M
Barak, N
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 92S - 92S
[4] Phase II study of neoadjuvant weekly paclitaxel and carboplatin with lapatinib in HER2+breast cancer.
Wong, Andrea Li Ann
Tan, Sing Huang
Soh, I. Peng Thomas
Tan, Chee Seng
Lim, Yi Wan
Pang, Angela
Ho, Jingshan
Ow, Samuel Guan Wei
Sundar, Raghav
Pang, Mei-Yan
Chan, Ching-Wan
Buhari, Shaik Ahmad
Hartman, Mikael
Iau, Philip
Tang, Anthony
Wong, Nan-Soon
Yap, Yoon Sim
Khoo, Bee-Luan
Thiery, Jean Paul
Lee, Soo-Chin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[5] Adriamycin-cytoxan followed by weekly taxol as neoadjuvant treatment in localised breast cancer
Leviov, M.
Leitzin, L.
Keren, S.
Rabkin, A.
Shklar, Z.
Steiner, M.
Biterman, A.
Shiloni, E.
[J]. BREAST, 2007, 16 : S48 - S49
[6] Adriamycin based therapy followed by weekly taxol as neoadjuvant treatment in localised breast cancer
不详
[J]. BREAST, 2005, 14 : S40 - S40
[7] Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast CancerA Phase II Study
David Sarid
Ilan G. Ron
Fani Sperber
Yona Stadler
Perry Kahan
Felix Kovner
Rami Ben-Yosef
Sylvia Marmor
Yulia Grinberg
Natalie Maimon
Juliana Weinstein
Neora Yaal-Hahoshen
[J]. Clinical Drug Investigation, 2006, 26 : 691 - 701
[8] A phase II trial of paclitaxel (Taxol(R)) as first line treatment in advanced breast cancer
Swain, SM
Honig, SF
Tefft, MC
Walton, L
[J]. INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 217 - 222
[9] Neoadjuvant chemotherapy in the treatment of operable breast cancer. Preliminary results of a phase II pilot study
Bellantone, R
Lombardi, CP
Cefaro, GA
Rossi, S
Nardone, L
Minelli, S
Raffaelli, M
De Crea, C
Crucitti, F
[J]. 10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 743 - 746
[10] Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer.
Kwa, Maryann J.
Tray, Nancy
Esteva, Francisco J.
Novik, Yelena
Speyer, James L.
Oratz, Ruth
Meyers, Marleen Iva
Muggia, Franco
Ty, Victor
Troxel, Andrea
Schneider, Robert
Adams, Sylvia
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

← 1 2 3 4 5 →